Ipswich Investment Management Co. Inc. grew its position in The Procter & Gamble Company (NYSE:PG - Free Report) by 5.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 48,832 shares of the company's stock after buying an additional 2,607 shares during the period. Procter & Gamble makes up about 2.1% of Ipswich Investment Management Co. Inc.'s investment portfolio, making the stock its 13th largest holding. Ipswich Investment Management Co. Inc.'s holdings in Procter & Gamble were worth $8,322,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in PG. Cladis Investment Advisory LLC increased its position in shares of Procter & Gamble by 5.2% during the 4th quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock valued at $806,000 after purchasing an additional 236 shares during the last quarter. FAS Wealth Partners Inc. lifted its position in shares of Procter & Gamble by 2.0% in the fourth quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company's stock valued at $4,642,000 after acquiring an additional 549 shares in the last quarter. Berkshire Asset Management LLC PA boosted its stake in Procter & Gamble by 0.9% in the 4th quarter. Berkshire Asset Management LLC PA now owns 236,616 shares of the company's stock worth $38,833,000 after purchasing an additional 2,179 shares during the period. Strategic Advisors LLC grew its stake in Procter & Gamble by 3.4% during the fourth quarter. Strategic Advisors LLC now owns 55,912 shares of the company's stock valued at $9,374,000 after acquiring an additional 1,818 shares in the last quarter. Finally, Natural Investments LLC purchased a new stake in shares of Procter & Gamble in the fourth quarter worth about $2,121,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Stock Performance
NYSE:PG traded down $3.12 during midday trading on Friday, hitting $160.06. The company's stock had a trading volume of 7,093,816 shares, compared to its average volume of 7,367,226. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The firm's 50 day moving average is $163.75 and its 200-day moving average is $166.82. The Procter & Gamble Company has a fifty-two week low of $156.58 and a fifty-two week high of $180.43. The firm has a market cap of $375.27 billion, a P/E ratio of 25.49, a P/E/G ratio of 3.76 and a beta of 0.43.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.54 EPS for the quarter, topping the consensus estimate of $1.53 by $0.01. The business had revenue of $19.78 billion for the quarter, compared to analyst estimates of $20.42 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business's quarterly revenue was down 2.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.52 EPS. Equities analysts anticipate that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.64%. This is an increase from Procter & Gamble's previous quarterly dividend of $1.01. The ex-dividend date of this dividend was Monday, April 21st. Procter & Gamble's dividend payout ratio is presently 66.98%.
Insider Buying and Selling at Procter & Gamble
In related news, insider Moses Victor Javier Aguilar sold 10,520 shares of Procter & Gamble stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the transaction, the insider now owns 25,182 shares in the company, valued at approximately $3,995,627.94. This trade represents a 29.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Jennifer L. Davis sold 1,000 shares of the firm's stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the sale, the chief executive officer now owns 51,965 shares of the company's stock, valued at approximately $8,386,111.70. The trade was a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.18% of the company's stock.
Analysts Set New Price Targets
Several equities analysts have commented on the stock. Royal Bank of Canada upgraded shares of Procter & Gamble from a "sector perform" rating to an "outperform" rating and increased their price objective for the company from $164.00 to $177.00 in a research report on Friday, April 25th. Citigroup decreased their target price on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Erste Group Bank lowered Procter & Gamble from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Evercore ISI reissued an "outperform" rating and set a $190.00 target price (up previously from $170.00) on shares of Procter & Gamble in a research report on Tuesday, June 3rd. Finally, Truist Financial decreased their price objective on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Eight investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $178.86.
Check Out Our Latest Research Report on Procter & Gamble
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report